With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing epidemic of cardiovascular diseases through sessions spotlighting the most recent and relevant research.
With increasing smartphone and digital device usage, there is a growing opportunity for technological tools to be incorporated into diabetes self-management (DSME). Although studies are limited thus far, scientific advancements in diabetes care have reduced long-term complications by improving glucose control, and simplifying disease management. Poor glucose control can lead to long-term diabetes, micro- and macro-vascular complications, and other health issues: all of which generate higher morbidity and mortality rates. The CDC reports that 100 million U.S. adults live with diabetes or prediabetes: a number expected to rise to 592 million by 2035.